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Abstract
Background:  Few studies have examined the attitude of medical practitioners towards the
availability of emergency contraception (EC) without prescription. In Indonesia, EC (either Yuzpe
regimen or Postinor-2) is available by prescription only. We aimed to examine the level of
knowledge, attitudes and practices of medical practitioners in Indonesia about EC, in particular
their attitudes to the availability of EC over-the-counter (OTC), using a questionnaire.
Methods: Data were collected by an anonymous structured questionnaire. Questionnaires were
distributed to general practitioners in 36 Community Health Centres and 25 private clinics using
stratified random sampling according to area in Jakarta, and to obstetricians practicising in 24
government and private hospitals and eight private clinics in Jakarta. Two hundred and five general
practitioners and 142 obstetricians and gynaecologists participated; overall response rate was 75%.
Results:  Although most participants were familiar with EC, only 22% received a very good
knowledge score (4 or 5/5 answers correct), while 52% received a poor score (0–2/5 correct).
Most participants did not support the OTC availability of EC (70%). Logistic regression identified
that participants who prescribed EC had an Odds of 3.8 (95% CI 1.90, 7.73) of approving OTC EC,
after adjustment for age and speciality.
Conclusion: Although many organisations are working towards OTC availability of EC, it needs
to be recognized and addressed that doctors who do not prescribe EC are unlikely to support the
increased availability of EC.
Background
Family planning practitioners and women's health advo-
cates have been campaigning for increased availability of
emergency contraception (EC) [1-4]. Grimes and col-
leagues have stated that EC meets all the criteria for over-
the-counter (OTC) use such as low toxicity, no potential
for overdose or addiction, no teratogenicity, no need for
medical screening, self-identification of need, uniform
dosage, and no important drug interactions [2]. In many
countries EC is now available OTC from pharmacies, after
a consultation with a trained pharmacist, but without a
doctor's prescription [5].
The progestogen-only regimen, using two 0.75 mg lev-
onorgestrel tablets either together or 12 hours apart, is
more effective than the Yuzpe regimen in preventing
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pregnancy (RR 0.51; 95% CI 0.31, 0.83) [6] and is availa-
ble pre-packaged as Postinor-2 or Plan B [3,4].
Only a small number of studies have examined the atti-
tude of medical practitioners towards the availability of
EC without prescription. Although Postinor-2 is available
OTC in Vietnam, the majority of family planning workers
participating in focus groups favoured availability by doc-
tor's prescription [7]. Most health care providers inter-
viewed in Mexico City (n = 40) favoured distribution of
EC through hospitals and clinics [8]. Interviews with fam-
ily planning providers in Kenya found a mixed response
to distribution of EC; some providers expressing concern
that pharmacists may not be able to monitor the distribu-
tion as well as family planning clinics [9]. Other studies
also found that a low proportion of health care providers
believed EC should be available through pharmacies: nine
percent of health care providers surveyed in Nigeria (n =
735) [10] and 22% of GPs and O&Gs in India (n = 130)
[11]. Although only 14% of practitioners surveyed in Min-
nesota, USA (n = 495), supported OTC availability of EC,
63% of physicians approved a trained pharmacist provid-
ing EC after conducting a focused history, making appro-
priate referrals to a physician for STD screening, sexual
assault counselling, physical exam, etc (if indicated) [12].
In Indonesia, EC is available by prescription only, either
the Yuzpe regimen (eg 2 Neogynon pills, repeated in 12
hours) or progestogen-only (Postinor-2) [13].
This study aimed to examine the level of knowledge, atti-
tudes and practices of medical practitioners in Indonesia
about EC, in particular their attitudes to the OTC availa-
bility of EC. The only study of providers' knowledge and
attitudes to EC in Indonesia which we identified is an
unpublished study by Lubis and colleagues cited by the
Consortium for Emergency Contraception [14]. Only
25% of health care providers (GPs, O&Gs, nurse-mid-
wives) and policy makers (family planning program man-
agers, members of professional associations, Ministry of
Health officials, and religious and community leaders)
were familiar with EC [14].
Methods
Study subjects
The study participants were medical practitioners in
Jakarta, Indonesia. The researchers aimed to distribute
questionnaires to 210 GPs and 250 obstetricians and
gynaecologists (O&Gs). In Indonesia patients may self-
refer to obstetricians and gynaecologists.
The Provincial Health Service-Jakarta (Suku Dinas Kese-
hatan DKI Jakarta) provided a list of Community Health
Centres (CHCs) (Pusat Kesehatan Masyarakat (Puskes-
mas)) and private clinics in five municipalities in Jakarta.
Thirty six CHCs and 25 private clinics were chosen using
stratified random sampling according to area, from the
total of 328 CHCs at district and village levels and 63 pri-
vate clinics in Jakarta. A research assistant distributed the
questionnaires to the CHCs and clinics along with a cul-
turally-appropriate token of appreciation (souvenir pen),
and later collected the completed questionnaires.
The Department of Obstetrics and Gynaecology, Faculty
of Medicine, the University of Indonesia, Ciptoman-
gunkusumo's Hospital (Bagian Obstetri dan Ginekologi,
Fakultas Kedokteran-Universitas Indonesia, Rumah Sakit
Ciptomangunkusumo) approved the study and distrib-
uted the questionnaires to O&Gs practicing in 24 govern-
ment and private hospitals and eight private clinics in
Jakarta.
Survey instrument
Data were collected by an anonymous structured ques-
tionnaire consisting of 30 questions. The first section col-
lected data about the socio-demographic and work
characteristics of the participants. The second section
assessed the knowledge, attitudes and practices of the par-
ticipants about EC. Participants were asked if they had
ever heard of the terms "emergency contraception",
"morning-after pill" or "post coital contraception" and if
they were familiar with the specially packaged emergency
contraceptive pill, Postinor-2. Knowledge about Postinor-
2 was assessed using five statements, with the responses
"true", "false" or "not sure". Five statements regarding par-
ticipants' attitudes towards the availability of EC as an
OTC product were provided with a 5-point Likert scale. In
addition, two case scenarios were provided to indicate cir-
cumstances in which participants would prescribe EC to
their patients, with 5-point Likert scale responses.
The final item on the questionnaire was an invitation for
participants to make free- text comments: "We are inter-
ested in your thoughts about emergency contraception,
please write any comments here". After pilotting with a
small number of Australian and Indonesian doctors and
medical students, some minor alterations were made to
the survey.
Translated questionnaires were copied in Melbourne and
sent to Indonesia for distribution. Participants were given
the questionnaire along with a Plain Language Statement
and a letter of a support from either the GP or O&G organ-
isation, as appropriate. Data collection took place in Feb-
ruary and March 2004, and completed questionnaires
were couriered back to Melbourne in April 2004 for data
entry and analysis.BMC Women's Health 2005, 5:3 http://www.biomedcentral.com/1472-6874/5/3
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Table 1: Demographic and clinical work characteristics of participants
Characteristics GP (n = 205) O&G (n = 142) Total (n = 347)
n%n%n%
Gender
Male 80 39 108 76 188 54
Female 125 61 34 24 159 46
Age
Mean age (years old) 39 45 42
Younger 121 59 51 36 172 50
O l d e r 8 34 19 16 4 1 7 4 5 0
Missing 1 1
Current martial status
Single 55 27 1 1 56 16
Married 146 71 137 96 283 82
Divorced 3231
W i d o w /  w i d o w e r 421151
Religion
I s l a m 1 0 85 31 2 78 92 3 56 8
Catholic 39 19 5 4 44 13
Protestant 48 24 9 6 57 16
H i n d u 101121
B u d d h i s t 73 72
Other 1 0 1 0
Missing 1 1
Location of work
J a k a r t a 1 8 79 21 3 19 43 1 89 3
O t h e r 316493
B o t h 1 3 621 1 5 4
Missing 2 3 5
Main place of work
Government hospital 73 58 73 23
Private hospital 5 3 38 30 43 14
Government clinic 2 1 2 1
Private clinic 80 43 15 12 95 30
Community health centre 99 53 99 32
(PUSKESMAS)1 1 1 0
Other 18 16 34
Provide advice on contraception in clinical work
Y e s 1 9 19 41 3 99 93 3 09 6
N o 1 2 621 1 4 4
Missing 2 1 3
Prescribed OC in the last six months
Y e s 1 3 36 61 2 68 92 5 97 5
No 70 34 15 11 85 25
Missing 2 1 3
All percentages are calculated on valid response only
GP: general practitioner, O&G: obstetrician and gynaecologist, OC: oral contraception
1Younger: 21 – 40 years, older: 41 – 70 yearsBMC Women's Health 2005, 5:3 http://www.biomedcentral.com/1472-6874/5/3
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Analysis
EpiData 3.0 [15]was used for data entry and Epi Info Ver-
sion 3.2 [16] and Stata 8.0 [17] were used for analysis. Fre-
quency and summary statistics were calculated for all var-
iables. Relevant variables were cross-tabulated and
Wilcoxon-Mann-Whitney and Kruskall-Wallis tests were
conducted to explore the association between the varia-
bles. A logistic regression model was developed to look at
the factors predictive of acceptance of the OTC availability
of EC (dependent variable). Independent variables were
speciality, gender, age, marital status, religion, knowledge
score, oral contraceptive pill prescriber and EC prescriber.
Stata 8 was used for this analysis.
Participants' comments were translated and typed in Eng-
lish. Selected comments were used to support and illus-
trate the main themes emerging from participants'
responses. This study was approved by the Human
Research Ethics Committee, The University of Melbourne.
Results
Two hundred and five of the 210 (97.6%) general practi-
tioners (GPs) and 142 of the 250 obstetricians and gynae-
cologists (O&Gs) (56.8%) completed the questionnaire,
yielding an overall response rate of 75% (347/460). Some
participants completed the demographic responses fully,
but did not complete all the responses about emergency
contraception, therefore denominators for responses vary.
Demographic and work characteristics of participants are
presented in Table 1. Fifty four percent of participants
were male, with a mean age of 42 years (range 24–68).
Most participants were married (82%) and the dominant
religious affiliation was Islam (68%). Almost all partici-
pants worked in Jakarta, the capital city of Indonesia
(93%).
The majority of participants provided advice on contra-
ception in their practices (GP 94%; O&G 99%). A higher
proportion of O&Gs had prescribed oral contraception
(OC) than GPs in the six months prior to the survey (O&G
89%; GP 66%).
More O&Gs had heard of the term "emergency contracep-
tion (EC)"or "morning-after pill" or "post coital contra-
ception" or "special pill preventing pregnancy" (O&G
130/141, 92%; GP 148/203, 73%). More than half the
GPs who answered this question were familiar with the
progestogen-only pill (POP) as an EC method (89/139,
64%). The two most common EC methods mentioned by
O&Gs were POP and the Yuzpe regimen (POP 88/127,
69%; the Yuzpe regimen 82/127, 65%). Fifty two percent
of GPs (78/150) and 66% of O&Gs (85/128) had heard of
Postinor-2 specifically. Participants reported hearing
about Postinor-2 from lectures, meetings or seminars (83/
273, 30%), journal articles (83/273, 30%) and their col-
leagues (69/273, 25%).
The results of the five knowledge questions are presented
in Table 2. Knowledge scores were regarded as very good
(4 or 5/5 correct), good (3/5 correct) or poor (0, 1 or 2/5
correct). Only 22% of participants received a very good
knowledge score, while 52% received a poor score.
Seventy percent (193/276) of the participants disap-
proved of the availability of EC as an over the counter
(OTC) product (GP 120/149, 81%; O&G 73/127, 57%).
Fourteen responded that they were "not sure".
Table 2: Knowledge about progestogen-only emergency contraception
GP (n = 151) O&G (n = 131) Total (n = 282)
n (m)♣ %n  ( m ) ♣ %n  ( m ) ♣ %
Correct responses to questions about POP, Postinor-2
Dosage: 0.7 5 mg levonorgestrel × 2 (T) 54 (12) 39 71 (10) 59 125 (22) 48
Timing of administration: within 84 hrs (F) 51 (8) 36 48 (8) 39 99 (16) 37
Causes abortion (F) 49 (8) 34 77 (7) 62 126 (15) 47
Fewer side-effects than Yuzpe regimen (T) 27 (7) 19 59 (8) 48 86 (15) 32
Efficacy 85% (T) 99 (7) 69 98 (7) 79 197 (14) 74
Knowledge score
Very good (4 or 5 out of 5 correct) 10 7 46 39 56 22
Good (3 out of 5 correct) 39 28 28 24 67 26
Poor (0 or 1 or 2 correct) 90 65 45 38 135 52
Missing 12 12 24
All percentages are calculated on valid response only
GP: general practitioner, O&G: obstetrician and gynaecologist, POP: progestogen-only pill, T: true, F: false
♣  The numbers in brackets are the missing valuesBMC Women's Health 2005, 5:3 http://www.biomedcentral.com/1472-6874/5/3
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Two case scenarios were provided to indicate circum-
stances in which participants would prescribe EC to their
patients. The majority of participants would prescribe EC
in the case of contraceptive failure in a married couple
(GP 105/146, 72%; O&G 112/130, 86%). Similarly, most
participants would also provide EC to a young woman
who had been raped (GP 97/146, 66%; O&G 118/130,
91%).
More O&Gs reported prescribing EC than GPs in the six
months before this survey (O&G 83/126, 66%; GP 74/
144, 51%). An equal proportion of GPs and O&Gs had
provided the Yuzpe regimen in their practices (GP 54/
144, 38%; O&G 49/129, 38%). In addition, 37% (48/
129) of O&Gs had also prescribed POP as EC (GP 28/144,
19%). About half the GPs had never prescribed EC in their
clinical practices (GP 70/144, 49%; O&G 43/129, 33%).
The IUD was also used more by O&Gs than GPs (O&G
18/119, 15%; GP 4/131, 3%).
Participants were dichotomized into two age groups (aged
40 years and below, and over 40 years). Older participants
were more knowledgeable about EC than younger partic-
ipants (z score = 2.071; p = 0.0384). However, stratifica-
tion by speciality resulted in no significant association
between level of knowledge and age group (GP, chi-
square = 3.0993, p = 0.212; O&G, chi-square = 0.0620, p
= 0.969). There was a significant difference in the knowl-
edge level between GPs and O&Gs (z score = 5.486; p <
0.0001), with O&Gs having higher knowledge scores.
Participants who prescribed oral contraception (OC) in
the six months before the survey were more likely to have
a "very good" level of knowledge, especially about Posti-
nor-2, than participants who had not prescribed OC (z
score = 3.381; p = 0.0007). The difference in the level of
knowledge about EC was not significantly related to gen-
der (z score = 1.765; p = 0.0775) or location of work (chi-
square with ties = 4.035; p = 0.2577).
Table 3: The association between approval for OTC availability of EC and other variables
Variables (n = 276) Approves EC as an OTC product Disapproves EC as an OTC product1
n%n%
Age group2
Younger 23 18 121 82 0.00254
O l d e r 4 33 48 56 6
Missing = 1
Gender
Male 47 30 112 70 0.0418
Female 22 19 95 81
Speciality
GP 25 17 124 83 0.0006
O & G 4 43 58 36 5
Location of work
Jakarta 63 25 190 75
Other 1 14 6 86 0.8569
Both 4 31 9 69
Missing = 3
Knowledge score3
Very good 19 34 37 66
Good 22 33 45 67 0.0086
Poor 25 19 110 82
Missing = 18
Prescribes EC
Yes 57 37 96 63 <0.0001
No 12 11 100 89
Missing = 5
EC: emergency contraception; GP: general practitioner, O&G: obstetrician and gynaecologist, OTC: over the counter
1Includes "not sure"
2Younger: 21 – 40 years, older: 41 – 70 years
3Very good (4 or 5 out of 5 correct), Good (3 out of 5 correct), and Poor (none or 1 or 2 out of 5 correct)
4Wilcoxon-Mann-Whitney test was used to examine the association between variables and attitude (Kruskall-Wallis test was used for location of 
work)BMC Women's Health 2005, 5:3 http://www.biomedcentral.com/1472-6874/5/3
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Table 3 presents the association between approval of OTC
availability of EC and age, gender, speciality, location of
work, knowledge score and prescribing EC. More male
participants accepted the OTC status of EC (z score =
2.036; p = 0.0418). O&Gs were more likely to accept EC
as an OTC product than GPs (z score = 3.410; p = 0.0006).
More older participants approved the OTC status of EC
product than younger participants (z score = 3.029; p =
0.0025). Most participants disapproved the availability of
EC OTC, however participants with "very good" and
"good" knowledge score were more likely to approve the
OTC status of EC than participants with "poor" knowl-
edge (z score = 2.626; p = 0.0086). However, stratification
of attitude by speciality showed that significant difference
was only found among GPs (GP, chi-square = 11.7983, p
= 0.003; O&G, chi-square = 0.8995, p = 0.638).
The EC practices were different across age group, gender,
speciality, knowledge and attitude scores. Older GPs were
more likely to prescribe EC in their practices (older 69/
112, 62%; younger 75/157, 48%; z score = 2.239; p =
0.0252). Male participants provided EC more commonly
than females (male 105/156, 67%; female 52/114, 46%;
z score = 3.562; p = 0.0004). In addition, being an O&G
was a positive predictor for prescribing EC (O&G 83/126,
66%; GP 74/144, 51%; z score = 2.402; p = 0.0163). Par-
ticipants who had better knowledge about EC were more
likely to provide EC (z score = 3.378; p = 0.0007). How-
ever, stratification of EC practice by speciality showed a
significant relationship between level of knowledge and
prescribing EC only for GPs (GP, Pearson chi-square =
6.6889, p = 0.035; P&G, Pearson chi-square = 3.4616, p =
0.177). Participants who accepted the OTC status of EC
were more likely to use EC in their clinical work (accepted
OTC status 57/69, 83%; disapproved OTC status 96/196,
49%; z score = 4.854; p < 0.0001).
A logistic regression model was developed to look at the
factors predictive of acceptance of the over-the-counter
availability of emergency contraception. The independent
variables (speciality, gender, age, marital status, religion,
knowledge score, OC prescriber and EC prescriber) were
tested individually against the dependent variable using
logistic regression to determine Odds Ratios. The p-values
of the Wald statistic for all variables were <0.05, except
religion which was 0.179 and marital which 0.693. Inde-
pendent variables were entered in the model if the p-value
of the Wald statistic was = 0.25 [18], therefore all variables
were entered initially except marital status. From the strat-
ified univariate analysis, it was recognized that age was a
confounding factor as it was associated with speciality;
therefore both were retained in the model. Records with
missing data on any of these variables were removed from
the sample, leaving 247 records for analysis.
Variables were eliminated one at a time using logistic
regression, only those with a p-value of the Wald statistic
of ≤  0.05 were retained in the model [18]. The process was
repeated until only significant variables remained. Then
the marital variable was added back into the model to
check that if it was now significant given the reduced
model. Interactions were examined between age and
speciality and age and sex. These were not retained in the
model as the Wald statistic p-values were > 0.01 (p =
0.623 and 0.525 respectively).
To check how closely aligned the predicted and observed
data values were, a 'goodness of fit' test was performed
(Hosmer-Lemeshow chi2(6) = 1.54, p = 0.9565); the non-
significant p value indicates a good fit. The sensitivity of
the model, that is, how often it correctly predicted the
outcome (y) given the value of a value of a covariate (x)
was tested using the area under the ROC curve. To be said
to have good discrimination, a model should have a sta-
tistical value of = 0.7 [18]. The lroc test identified that the
area under ROC curve was 0.7195. The lstat test showed
72.03% correctly classified. The final model, with Odds
Ratios, can be seen in Table 4.
Many participants made comments about the use of EC in
the final section of the questionnaire. Some participants
stressed the emergency nature of this method:
Table 4: Approval for OTC availability of EC
Unadjusted Multivariate analysis
Odds Ratio (95%CI) Adjusted Odds Ratio (95%CI)
EC prescriber No Reference Reference
Yes 4.35 (2.18, 8.68) 3.70 (1.83, 7.50)
Age (yrs) 21–40 Reference Reference
41–70 2.66 (1.49, 4.76) 1.96 (1.05, 3.66)
Speciality GP Reference Reference
O&G 2.37 (1.33, 4.23) 1.76 (0.94, 3.28)
EC: emergency contraception; GP: general practitioner, O&G: obstetrician and gynaecologistBMC Women's Health 2005, 5:3 http://www.biomedcentral.com/1472-6874/5/3
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• Agree on providing contraception/emergency contracep-
tive pill which might be used only in the case of contra-
ceptive failure (forgetting to take regular oral
contraceptive pill or condom leakage) (46 year-old male
O&G)
Some participants argued that EC would be beneficial to
reduce the abortion rate and prevent unwanted
pregnancy.
• Emergency contraception is very useful for people want-
ing to prevent pregnancy. (It) may reduce the abortion
rate as well as the complications of abortion (42 year-old
female GP)
Participants had concerns about the availability of EC
OTC in encouraging intercourse among unmarried cou-
ples especially adolescents.
• Do not market emergency contraception without pre-
scription because may lead to free sex among teenagers
which later causes STD, for example HIV AIDS (50 year-
old male GP)
Most participants indicated that EC should be available by
prescription.
• Emergency contraception should be given with prescrip-
tion, not to be sold as an over the counter drug! (35 year-
old female O&G)
Another theme was the need for more information about
EC for both professionals:
• Need symposium for doctors, midwives, health person-
nel (62 year-old male O&G)
and the community:
• Need more explanation/ information for public through
printed mass media/ TV/ radio (62 year-old male O&G).
Discussion
This survey of general practitioners (GPs) and obstetri-
cians and gynaecologists (O&Gs) in Indonesia has identi-
fied a low level of knowledge about emergency
contraception (EC). While the majority of medical practi-
tioners supported the availability and the use of EC, they
disapproved the availability of EC as an over the counter
(OTC) product. This survey also revealed that EC was pre-
scribed infrequently by Indonesian medical practitioners.
The higher response rate among GPs, 98%, compared to
O&Gs, 57%, was likely to be due to the different method
of recruitment. The research assistant visited GPs' work-
places and gave them a small token (pen), while O&Gs
received the questionnaire through their medical organi-
zation, without any contact with the researchers. How-
ever, although demographic questions were well
answered, many participants did not complete all the
questions; questions relating to prescribing practices were
completed by 70% of GPs (144/205).
In our study, O&Gs were more likely to be involved in
contraceptive care than GPs, and to be more familiar with
the concept of EC. Although O&Gs were more likely to
approve EC as an OTC product on univariate analysis, this
was not significant on multivariate analysis. Logistic
regression identified that participants who prescribed EC
had an Odds of 3.7 of approving over-the-counter EC after
adjusting for age and speciality.
There is a common misconception that EC is an abortifa-
cient. Twenty percent of family planning coordinators in
Michigan, USA, believed that EC worked by causing an
abortion [19]. Anna Glasier states "It cannot be stressed
too strongly that if hormonal emergency contraception
works largely by interfering with ovulation, then it cannot
be regarded as an abortifacient" [1 p1063].
A survey involving 100 O&Gs in Massachusetts, United
States revealed that 94% had prescribed EC, with 57%
reported prescribing it no more than five times per year
[20]. In contrast, only 76% of 96 family physicians
reported prescribing EC, and 82% of them prescribed it
five times or less [20]. Lower levels of prescribing have
been found in studies in developing countries. In Nairobi,
Kenya, only 15% of family planning providers reported
prescribing EC [9] and only 20% of primary health care
workers recommended EC in Turkey [21]. In our survey,
66% of O&Gs and 51% of GPs reported prescribing EC in
the previous six months, but as many participants did not
complete this question, this should be regarded as an
overestimate of prescribing practices.
A survey of family physicians and nurses (n = 78) in the
USA found that practitioners who prescribed EC were
more likely to agree that the benefits outweigh the risks
(94%) than nonprescribers (50%) [22]. All of the nonpre-
scribers (n = 7) agreed that they felt uncomfortable pre-
scribing EC for religious / ethical reasons, compared to
8% of the prescribers [22].
The low level of support for OTC availability of EC found
in our study is similar to the results of other studies
[7,10,11]. A study in Oxford, UK, in which 76 GPs were
interviewed in 1996, found that only eight of the GPs
reported unqualified enthusiasm for deregulation of EC
[23]. The four main themes expressed by the GPs were
that women would be missing out on the benefits of thePublish with BioMed Central    and   every 
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consultation; that EC is not the most effective, or safe,
form of contraception; that some women may use it fre-
quently; and that the pharmacy has characteristics which
make it unsuitable for dispensing EC [23]. Ziebland has
suggested that health professionals may feel uncomforta-
ble with EC, because in contrast to other methods of con-
traception, the provision of EC is closely associated with a
sexual episode [24].
Conclusion
Medical practitioners in Indonesia would benefit from
additional education about EC. Medical practitioners
should be encouraged to include discussion of EC in their
routine consultations with women about contraception.
Although many organisations are working towards OTC
availability of EC, it needs to be recognized and addressed
that doctors who do not prescribe EC are unlikely to sup-
port the increased availability of EC.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
Both authors participated in the design, conduct and anal-
ysis of the study. Both authors read and approved the final
manuscript.
Acknowledgements
The Key Centre for Women's Health in Society, University of Melbourne, 
for assisting with costs of photocopying and postage. The authors would 
also like to thank the doctors for participating.
References
1. Glasier A: Emergency postcoital contraception. The New Eng-
land Journal of Medicine 1997, 337:1058-1064.
2. Grimes DA, Raymond EG, Scott Jones B: Emergency contracep-
tion over-the-counter: the medical and legal imperatives.
Obstetrics and Gynecology 2001, 98:151-155.
3. Foran T: Emergency contraception.  Australian Family Physician
2002, 31:909-912.
4. Camp SL, Wilkerson DS, Raine TR: The benefits and risks of
over-the-counter availability of levonorgestrel emergency
contraception. Contraception 2003, 68:309-317.
5. Fenichel RR: Which drugs should be available over the coun-
ter? (Editorial). BMJ 2004, 329:182-183.
6. Cheng L, Gulmezoglu AM, Ezcurra E, Van Look PF: Interventions
for emergency contraception. Cochrane Database of Systematic
Reviews 2000:CD001324.
7. Ngoc NTN, Ellertson C, Surasrang Y, Loc LT: Knowledge and atti-
tudes about emergency contraception among health work-
ers in Ho Chi Minh City, Vietnam. International Family Planning
Perspectives 1997, 23:68-72.
8. Langer A, Harper C, Garcia-Barrios C, Schiavon R, Heimburger A,
Elul B, Renoso Delgado S, Ellertson C: Emergency contraception
in Mexico City: what do health care providers and potential
users know and think about it? Contraception 1999, 60:233-241.
9. Muia E, Ellertson C, Lukhando M, Flul B, Clark S, Olenja J: Emer-
gency contraception in Nairobi, Kenya: knowledge, attitudes
and practices among policymakers, family planning provid-
ers and clients, and university students.  Contraception 1999,
60:223-232.
10. Adekunle AO, Arowojolu AO, Adedimeji AA, Okunlola MA: Emer-
gency contraception: survey of knowledge, attitudes and
practice of health care professionals in Ibadan, Nigeria. Jour-
nal of Obstetrics and Gynaecology 2000, 20:284-289.
11. Tripathi R, Rathore AM, Sachdeva J: Emergency contraception:
knowledge, attitude, and practices among health care pro-
viders in North India.  The Journal of Obstetrics and Gynaecology
Research 2003, 29:142-146.
12. Kumar AS, Hall LC, LePage A, Lim PC: Providing emergency con-
traceptive pills "behind-the-counter": opinions among Min-
nesota healthcare providers. Contraception 2003, 68:253-259.
13. Saifuddin AB, Affandi B, Lu ER: Buku panduan praktis pelayanan
kontrasepsi (Practical guidelines for contraceptive services).
Jakarta, Yayasan Bina Pustaka Sarwono Prawirohardjo; 2003. 
14. Lubis F, Prihartono J, Djuarini S: Baseline data on ECPs Study
(Indonesia). Jakarta, World Health Organization (WHO) and
Yayasan Kusuma Buana (YKB); 1997. 
15. Lauritsen JM, Bruus M: EpiData-An extended tool for validated
data-entry and documentation of data. 3.0th edition. Odense,
Denmark, The EpiData Association; 2003. 
16. Dean AG, Arner TG, Sunki GG, Friedman R, Lantinga M, Sangam S,
Zubieta JC, Sullivan KM, Brendel KA, Gao Z, Fontaine N, Shu M,
Fuller G: Epi Info, a database and statistics program for public
health professionals Version 3.2. 3.2th edition. Atlanta, Georgia,
Centers for Disease Control and Prevention; 2004. 
17. StataCorp: Stata Statistical/ Data Analysis 8.0. College Station,
Texas, Stata Corporation; 2003. 
18. Hosmer DW, Lemeshow S: Applied logistic regression. New
York, John Wiley & Sons, Inc; 2000. 
19. Brown JW, Boulton ML: Provider attitudes toward dispensing
emergency contraception in Michigan's Title X programs.
Family Planning Perspectives 1999, 21:39-43.
20. Chuang CH, Waldman LJ, Freund KM, Ash AS: Emergency contra-
ception: prescribing practices of general internists com-
pared with other primary care physicians. Contraception 2004,
69:43-45.
21. Mandiracioglu A, Mevsim V, Turgul O: Health personnel percep-
tions about emergency contraception in primary health-care
centers. The European Journal of Contraception & Reproductive Health
Care 2003, 8:145-149.
22. Wallace JL, Wu J, Weistein J, Gorenflo DW, Fetters MD: Emer-
gency contraception: knowledge and attitudes of family
medicine providers. Fam Med 2004, 36:417-422.
23. Ziebland S, Graham A, McPherson A: Concerns and cautions
about prescribing and deregulating emergency contracep-
tion: a qualitative study of GPs using telephone interviews.
Family Practice 1998, 15:449-456.
24. Ziebland S: Emergency contraception: an anomalous position
in the family planning repertoire.  Soc Sci Med 1999,
49:1409-1417.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6874/5/3/prepub